Infection by hepatitis C virus through contaminated intravenous immune globulin : results of a prospective national inquiry in France.
A recent hepatitis C virus (HCV) outbreak has been suspected of being caused by an infusion of intravenous immune globulin.
Study Design and Methods
Three laboratories were mandated by the French regulatory agency to prospectively screen on a national scale those persons having received suspected batches : 233 exposed patients were recalled and tested for HCV antibody and for HCV RNA.
Nineteen patients (8.1%) were found positive for HCV RNA ; 7 of these 19 were positive for the HCV antibody.
The link between HCV infection and intravenous immune globulin was reinforced by the overrepresentation of the 2b genotype (58%), which contrasts with the low prevalence of this genotype in France (1%).
Mots-clés Pascal : Hépatite virale C, Virose, Infection, Immunoglobuline, Voie intraveineuse, Origine humaine, Contamination, Epidémiologie, Traitement, Complication, Homme, France, Europe, Incidence, Appareil digestif pathologie, Foie pathologie, Transfusion, Constituant sang
Mots-clés Pascal anglais : Viral hepatitis C, Viral disease, Infection, Immunoglobulins, Intravenous administration, Human origin, Contamination, Epidemiology, Treatment, Complication, Human, France, Europe, Incidence, Digestive diseases, Hepatic disease, Transfusion, Blood product
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0320406
Code Inist : 002B27D01. Création : 10/04/1997.